These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2613294)

  • 41. Exposure to ultraviolet radiation enhances mortality and pathology associated with influenza virus infection in mice.
    Ryan LK; Neldon DL; Bishop LR; Gilmour MI; Daniels MJ; Sailstad DM; Selgrade MJ
    Photochem Photobiol; 2000 Oct; 72(4):497-507. PubMed ID: 11045721
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effect of anti-influenza virus H3N2 of Hypericum japonicum in vivo].
    Liu N; Hu XL; Meng YR; Zhu YT; Huang BS; Lin PZ
    Zhong Yao Cai; 2008 Jul; 31(7):1022-4. PubMed ID: 18973021
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tumor necrosis factor as a mediator of inflammation in influenza A viral pneumonia.
    Peper RL; Van Campen H
    Microb Pathog; 1995 Sep; 19(3):175-83. PubMed ID: 8559046
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Functional analysis of the TCR alpha- beta+ cells that accumulate in the pneumonic lung of influenza virus-infected TCR-alpha-/- mice.
    Eichelberger M; McMickle A; Blackman M; Mombaerts P; Tonegawa S; Doherty PC
    J Immunol; 1995 Feb; 154(4):1569-76. PubMed ID: 7836742
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Experimentally induced respiratory syncytial viral infection in calves.
    Mohanty SB; Ingling AL; Lillie MG
    Am J Vet Res; 1975 Apr; 36(4 Pt.1):417-9. PubMed ID: 164807
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protective effects of recombinant human granulocyte macrophage colony stimulating factor on H1N1 influenza virus-induced pneumonia in mice.
    Huang H; Li H; Zhou P; Ju D
    Cytokine; 2010 Aug; 51(2):151-7. PubMed ID: 20427198
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prior exposure to acrolein accelerates pulmonary inflammation in influenza A-infected mice.
    Ong FH; Henry PJ; Burcham PC
    Toxicol Lett; 2012 Aug; 212(3):241-51. PubMed ID: 22705057
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influenza infection in the infant mouse.
    Reuman PD; Ayoub EM; Small PA
    Pediatr Res; 1983 May; 17(5):338-43. PubMed ID: 6856395
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Maternal-infant transfer of influenza-specific immunity in the mouse.
    Reuman PD; Paganini CM; Ayoub EM; Small PA
    J Immunol; 1983 Feb; 130(2):932-6. PubMed ID: 6848601
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antiviral effects of rhIFN-alpha 1 against seven influenza viruses.
    Li F; Wang QJ; Zhu BL; Wang M
    Zhongguo Yao Li Xue Bao; 1999 Aug; 20(8):709-14. PubMed ID: 10678103
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia.
    Le Goffic R; Balloy V; Lagranderie M; Alexopoulou L; Escriou N; Flavell R; Chignard M; Si-Tahar M
    PLoS Pathog; 2006 Jun; 2(6):e53. PubMed ID: 16789835
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anti-high mobility group box-1 monoclonal antibody treatment provides protection against influenza A virus (H1N1)-induced pneumonia in mice.
    Nosaka N; Yashiro M; Yamada M; Fujii Y; Tsukahara H; Liu K; Nishibori M; Matsukawa A; Morishima T
    Crit Care; 2015 Jun; 19(1):249. PubMed ID: 26067826
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effect of electroacupuncture stimulation of "Feishu" (BL 13) on lung index, serum and lung IL-10 and TNF-alpha levels in mice with viral pneumonia].
    Luo W; Wang JY; Liu CL; Huang C
    Zhen Ci Yan Jiu; 2014 Aug; 39(4):293-7. PubMed ID: 25219125
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Kinetic profile of influenza virus infection in three rat strains.
    Daniels MJ; Selgrade MK; Doerfler D; Gilmour MI
    Comp Med; 2003 Jun; 53(3):293-8. PubMed ID: 12868575
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of Trypanosoma equiperdum on the lesions of experimental influenza virus pneumonia.
    Oyejide A; Wheeldon EB; Moulton JE; Wolcott JA
    J Comp Pathol; 1982 Apr; 92(2):169-75. PubMed ID: 7085937
    [No Abstract]   [Full Text] [Related]  

  • 56. Experimentally induced porcine proliferative and necrotising pneumonia with an influenza A virus.
    Girard C; Morin M; el Azhary Y
    Vet Rec; 1992 Mar; 130(10):206-7. PubMed ID: 1324542
    [No Abstract]   [Full Text] [Related]  

  • 57. The use of plethysmography in determining the severity of lung pathology in a mouse model of minimally lethal influenza virus infection.
    Julander JG; Kesler K; Van Wettere AJ; Morrey JD; Smee DF
    Antiviral Res; 2014 Aug; 108():10-3. PubMed ID: 24837607
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prophylactic and therapeutic combination effects of rimantadine and oseltamivir against influenza virus A (H3N2) infection in mice.
    Simeonova L; Gegova G; Galabov AS
    Antiviral Res; 2012 Aug; 95(2):172-81. PubMed ID: 22617756
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enhancement of influenza virus infections by secalonic acid D.
    Fleischhacker DS; Akers TG; Katz SP; Palmgren MS
    Environ Health Perspect; 1986 Apr; 66():113-8. PubMed ID: 3011393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.